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Public healthAbstract Poultry meat and its products are widely consumed by humans globally, however,
Aeromonas infections in poultry have been reported in different parts of the world with devastating
effects. This study was carried out to assess the antibiogram and bioﬁlm forming potential of
Aeromonas isolated from chicken fecal samples. Aeromonas isolates were screened for antibiotic sus-
ceptibility using antibiotics disk and bioﬁlm producing potentials on abiotic surfaces. Nineteen iso-
lates recovered from chicken feces were 100% sensitive to ciproﬂoxacin, gentamicin and the
tetracyclines. About 53% of Aeromonas isolates were resistant to erythromycin and 47% resistant
to streptomycin. Eight isolates (42.1%) were found to be moderate producers of bioﬁlm, 31.6%
(6/19) were weak producers of bioﬁlm, 10.5% (2/19) were non bioﬁlm producers while 15.8%
(3/19) were strong producers. The present investigation shows a prevalence of potentially pathogenic
Aeromonas strains in chicken feces, suggesting potential group at risk for Aeromonas infection which
could be dissemination to other animals or humans with close contact and the wider community.
ª 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Poultry meat and its products are among the most widely
consumed food all over the world. Chicken meat is delicious,
nutritious and a good source of protein characterized by good
ﬂavor and easily digested. Aeromonas infections in poultry
have been reported in different parts of the world withdevastating effects (Dashe et al., 2013). A higher occurrence
of Aeromonas from chicken source (Smita and Brahmabhatt,
2011) suggests that chicken could be a potential host for the
spread of Aeromonas infection and present a possible threat
to public health. Considering the high frequency of Aeromonas
in poultry stool samples (Jindal et al., 1993), poultry carcasses
and poultry plant processing water (Barnhart et al., 1989;
Zanella et al., 2012), there is need to investigate the presence
of Aeromonas in chicken samples.
Aeromonas species has the ability of colonizing several
ecological niches. Aeromonas intestinal colonization is as a
result of several virulence factors. Virulence in Aeromonas is
multifactorial and not yet understood. Microbial colonization
of mucosal surfaces is a complex process which results in infec-
tion, however, for most microbial infections it is thought to
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isms entrenched in a polysaccharide matrix of their own mak-
ing and adhering to a surface. Bacteria in bioﬁlms are free-
ﬂoating planktonic cells and show more resistance to antimi-
crobial agents and host defenses. They may also express more
virulent phenotypes as a result of gene activation through bac-
terial communication (‘‘quorum sensing’’) or gene transfer
(Greenberg, 1999; Costerton et al., 1999; Kirov et al., 2002).
An important component in bioﬁlm formation is the ability
to move over and colonize surfaces after the initial attachment.
Aeromonas species have been described as an emerging food
borne pathogen involved in human gastroenteritis ranging
from mild diarrheal to cholera-like illness (Vila et al., 2003;
Igbinosa et al., 2012). Aeromonas has also been implicated in
meningitis, cellulites, otitis, endocarditis, osteomyelitis, perito-
nitis, bacteremia, and septicemia, among others diseases
(Albert et al., 2000; Zanella et al., 2012). Aeromonas spp. have
emerged as important human pathogens associated with food
borne disease outbreaks (Fukushema et al., 2007; Awaad
et al., 2011; Dashe et al., 2013). Biochemically, Aeromonas
are Gram negative rods, oxidase and catalase positive, faculta-
tive anaerobe, motile, glucose fermenting. The ubiquitous nat-
ure of Aeromonas in aquatic, clinical and environmental
sources has made it possible for forms of life such as human
and domestic animals to have close contact with and become
infected with Aeromonas species. Aeromonas have been impli-
cated in water and food borne disease outbreak in different
parts of the world especially in developing countries where
hygiene and access to quality water supply is a challenge
(Odeyemi and Ahmad, 2013).
The use of antibiotics has been vital in the treatment of infec-
tious diseases caused by bacteria which has contributed to the
rise in average life expectancy in the Twentieth century. How-
ever, bacteria that cause disease have become resistant to antimi-
crobial chemotherapy and are an increasing public health
challenge (Sharma et al., 2010). The antibiotic susceptibility of
an isolate is usually required for effective clinical control.
Microbial resistance to antibiotics is partially as a result of
bacterial dynamism in adapting to its environment as well as
increasing use, and misuse, of existing antibiotics in agriculture,
human and veterinary medicine. Antimicrobial resistance
among enteric pathogens is a part of major problem in develop-
ing countries where there is a high occurrence of gastroenteric ill-
nesses and many antibiotics fall routinely into inadequate use.
Antibiotic resistance is mostly pertinent in pathogenic Aeromo-
nas species due to the frequent occurrence of multiple antibiotic
resistances besides the classical resistance to beta-lactamic anti-
biotics (Kampfer et al., 1999; Vila et al., 2002). Also, these bac-
teria could possess integron (Igbinosa et al., 2013) which enables
them to receive and transfer antibiotic resistance genes, giving
rise to the risk from resistant bacterial infections (Marchandin
et al., 2003; Zanella et al., 2012). There is a need for periodic sur-
veillance of drug resistance of these organisms in different geo-
graphical areas and different sources for appropriate guidance
for choice of antimicrobial agent for empiric therapy.
2. Materials and methods
2.1. Isolation procedure
The survey area of the study was Fort Cox agricultural farm in
the Eastern Cape province of South Africa. Chicken fecalsamples were collected at random in the months of September
and December 2010 from the poultry segment of the farm and
transported to the laboratory in cold chain. About 10 g of
samples was inoculated in buffered peptone water (pH 7.2)
for enrichment and incubated at 36 C for 18–24 h. Enriched
culture media were spread onto GSP agar plates for Aeromo-
nas isolation. After 24 h incubation, phenotypic yellow colo-
nies were picked and puriﬁed (Igbinosa et al., 2013). Pure
colonies were transferred unto nutrient agar plates and slants.
Isolates were identiﬁed based on biochemical characteristics
using API 20NE proﬁling kit. The strips were then read, and
ﬁnal identiﬁcation was made using API lab plus software (bio-
Merieux, Marcy l’Etoile, France).
2.2. Antibiotic phenotyping of isolates
Antibiotic susceptibilities of isolates were carried out using the
following antibiotics: amoxycillin (30 lg), ampicillin–
sulbactam (20 lg), aztreonam (30 lg), cefotaxime (30 lg),
cephalothin (30 lg), chloramphenicol (30 lg), ciproﬂoxacin
(5 lg), erythromycin (15 lg), gentamicin (10 lg), kanamycin
(30 lg), nalidixic acid (30 lg), neomycin (30 lg), nitrofuran-
toin (300 lg), norﬂoxacin (10 lg), oxytetracycline (30 lg), pen-
icillin G (10 lg), streptomycin (10 lg), tetracycline (10 lg),
tobramycin (10 lg), trimethoprim–sulfamethoxazole (25 lg).
Antibiotics were selected on the basis of antibiotics used as
food additive in agriculture and those used for the treatment
of Aeromonas associated infections. Pure isolates were grown
on nutrient agar plates for 18 h afterward 4–6 colonies were
suspended in normal physiological saline and adjusted to tur-
bidity of 0.5-M McFarland standard. Subsequently, the isolate
suspension was spread onto Muller Hinton agar (biolab)
plates. Plates were allowed to dry and impregnated with the
appropriate antibiotic disks. Plates were incubated at 36 C
for 24 h after which zones of inhibition were measured and
recorded (Igbinosa et al., 2013). The inhibition and zone mar-
gins were selected as the areas showing no visible growth. The
sizes of the zones were interpreted using published standards of
the Clinical Laboratory Standard Institute Guidelines (CLSI,
2006) and the isolates reported as susceptible, intermediate
or resistant against the antimicrobial agents tested.
2.3. Bioﬁlm formation assay
Aeromonas isolates were grown for 18 h in trypticase soy broth
at 36 C and centrifuged for 2 min at 12,000 rpm. Cell pellets
were washed and re-suspended in phosphate-buffered saline
(pH 7.2) turbidity equivalent of 0.5 McFarland standard
(Basson et al., 2007). Wells of sterile 96-well U-bottomed poly-
styrene microtiter plates was inoculated with 180 ll trypticase
soy broth and 20 ll of standardized cell suspensions in order to
determine bacteria adherence to abiotic material (Jacobs and
Chenia, 2011; Igbinosa et al., 2013). Aeromonas hydrophila
ATCC 7966 was used as positive control while wells containing
only broth were used as negative control. Microtitre plates
were incubated at 36 C for 24 h. The absorbance reading of
each well was obtained at 570 nm using an automated
microtiter-plate reader (Synergy mx BiotekR USA). Assays
were done in triplicate and the results averaged (Jacobs and
Chenia, 2011; Igbinosa et al., 2013). Bioﬁlm formation was
classiﬁed as non-adherent, weakly, moderately or
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plate test was deﬁned as three standard deviations above the
mean OD of the negative control. Isolates were classiﬁed as
follows: ODODC = non-adherent, ODC< OD(2 · ODC) =
weakly adherent; (2 · ODC) < OD 6 (4 · ODC) = moder-
ately adherent and (4 · ODC) < OD= strongly adherent
(Jacobs and Chenia, 2011; Igbinosa et al., 2013).3. Results and discussion
3.1. Occurrence of Aeromonas species
Biochemical identiﬁcation of isolates was carried out using
API 20NE kit. Based on biochemical identiﬁcation of isolates,
six Aeromonas species isolates were recovered from fecal
samples collected in September 2010 while thirteen Aeromonas
isolates were recovered from fecal samples collected in Decem-
ber 2010 resulting in a total of nineteen (19) isolates. Although,
other microorganisms might have been present in the samples,
however, Aeromonas was the interest microorganism of study.
The isolation media used differentially and selectively
narrowed the possibility of other microorganisms. Aeromonas
have the capability of adapting to different ecological niche
(Mateos et al., 1993; Arora et al., 2006) and possess astonish-
ing properties which permit their survival and ability to survive
and ﬂourish in diverse condition (Agarwal, 1997; Arora et al.,
2006), thereby allowing their cosmopolitan occurrence in
nature. Aeromonas recognition as an emerging food borne
pathogen is on the increase.
3.2. Antibiotic phenotyping of isolates
Most of the Aeromonas isolates were resistant to erythromycin
(macrolides) but were sensitive to tetracycline, chlorampheni-
col, nitrofurantoin, quinolone, ﬂuoroquinolones and amino-
glycosides as shown in Table 1. The tetracyclines showed
absolute sensitivity against all Aeromonas isolates. A similar
observation of Aeromonas susceptibility to tetracycline has
been reported in different geographical regions (Zanella
et al., 2012; Awan et al., 2009; Mahmoud and Tanios, 2008).
Although tetracycline has been used as growth stimulant in
poultry feed for many years, the low resistance Aeromonas
observed against tetracycline indicate minimal repercussion
of tetracycline as antibiotics of choice in poultry farming.
The aminoglycosides (gentamicin and tobramycin) showed
brilliant activity against Aeromonas isolates with gentamicin
showing absolute activity (Table 1). In a study carried out
by Awan et al. (2009), Aeromonas isolated from food samples
including fresh and frozen chicken demonstrated absolute sen-
sitivity to gentamicin. This also corroborates with the report of
(Dallal et al., 2012) who found excellent gentamicin activity
against Aeromonas isolated from minced meat and chicken
samples. The cephalosporins (cefotaxime) showed very high
potency against the isolates compared to (cephalothin) which
showed approximately average activity, which signify that Aer-
omonas species have variable susceptibility to cephalosporins.
Aeromonas resistance to ﬁrst generation cephalosporins, is
expected given that motile Aeromonas demonstrate beta-
lactamase activity and frequently the presence of metallo-
beta-lactamases of expanded effect (Morita et al., 1994).Trimethoprim-sulfamethoxazole complex showed apprecia-
ble susceptibility against Aeromonas isolates and resistance
rate of 36.8%. This observation is similar to reports of
(Zanella et al., 2012) and corroborates the ﬁnding of
Ghenghesh et al. (2013), in which all Aeromonas isolates from
chicken samples showed absolute sensitivity to Trimethoprim-
sulfamethoxazole. Although, some literature argue the effec-
tiveness of sulfamethoxazole–trimethoprim (SXT) complex
against Aeromonas as a result of reports of other authors
showing Aeromonas resistance (von Graevenitz and Altwegg,
1991). However, a study carried out on sulfamethoxazole
alone against Aeromonas isolates showed poor activity but as
a complex SXT, its efﬁcacy against the isolates improved sig-
niﬁcantly (Awan et al., 2009), which is in conformity with
the result obtained in the present study.
The penicillins (amoxycillin and penicillin) were absolutely
inactive against all isolates while a slight variability of Ampicil-
lin–sulbactam was insigniﬁcant. Several researchers have doc-
umented Aeromonas resistance to penicillins (Kaskhedikar and
Chhabra, 2009; Zanella et al., 2012; Ghenghesh et al., 2013). In
general, Most Aeromonas isolates are intrinsic or chromosom-
ally mediated resistance against ampicillin (Rall et al., 1998).
The resistance is as a result of at least four b-lactamases
(von Graevenitz and Altwegg, 1991; Awan et al., 2009). Apart
of the antimicrobial agent that showed absolute activity, the
following antibiotics showed excellent activity (>70% strains
were sensitive) against all the isolates tested. These include
aztreonam, cefotaxime, chloramphenicol, nalidixic acid, nitro-
furantoin, and tobramycin. A similar observation of Aeromo-
nas sensitivity to cefotaxime, chloramphenicol, nitrofurantoin
and tobramycin has been documented (Awan et al., 2009)
while Aeromonas sensitivity to aztreonam, nalidixic acid
among others has been reported (Zanella et al., 2012).
Aeromonas has been reported to show excellent sensitivity
against chloramphenicol nitrofurantoin and tetracycline (von
Graevenitz and Altwegg, 1991; Pasquale et al., 1994;
Vivekanandhan et al., 2002). A similar observation has been
documented (Awan et al., 2009) which is in accordance with
the result obtained in the present study.
3.3. Bioﬁlm formation assay
Bioﬁlm formation is considered a vital virulence factor, aiding
bacterial colonization by cell adhesion to epithelial cells and
intestinal villi, reducing bacterial sensitivity to antimicrobial
agents, and the reducing recognition of the bacteria by the
immunologic system (Davey and O’Toole, 2000; Zanella
et al., 2012). A quantitative assessment of bioﬁlm producing
potential of Aeromonas isolates showed signiﬁcant variation
among the isolates. Eight isolates (42.1%) were found to be
moderate producers of bioﬁlm while 6 (31.6%) of the isolates
were weak producers of bioﬁlm. In general, 2 (10.5%) isolates
were non producers of bioﬁlm whereas 3 (15.8%) were strong
producers as shown in Fig. 1. The existence of bioﬁlm forming
Aeromonas from poultry and poultry workers has been docu-
mented (Zanella et al., 2012), which corroborates the result
of this study. Aeromonas bioﬁlm forming ability was also
reported by Kirov et al. (2002), and was considered a potential
virulence factor.
In conclusion, the present investigations show a high prev-
alence of potentially pathogenic Aeromonas strains in chicken
Table 1 Patterns of Antibiotic phenotype of Aeromonas isolates from chicken feces.
Antimicrobial agents Susceptible Intermediate Resistance
No. % No. % No. %
Amoxycillin (30 lg) 0 0 0 0 19 100
Ampicillin–sulbactam (20 lg) 2 10.5 0 0 17 89.5
Aztreonam (30 lg) 16 84.2 0 0 3 15.8
Cefotaxime (30 lg) 16 84.2 2 10.5 1 5.3
Cephalothin (30 lg) 11 57.9 3 15.8 5 26.3
Chloramphenicol (30 lg) 14 73.7 1 5.3 4 21.1
Ciproﬂoxacin (5 lg) 19 100 0 0 0 0
Erythromycin (15 lg) 6 31.6 3 15.8 10 52.6
Gentamicin (10 lg) 19 100 0 0 0 0
Kanamycin (30 lg) 12 63.2 0 0 7 36.8
Nalidixic acid (30 lg) 15 78.9 1 5.3 3 15.8
Neomycin (30 lg) 12 63.2 4 21.1 3 15.8
Nitrofurantoin (300 lg) 15 78.9 0 0 4 20.1
Norﬂoxacin (10 lg) 13 68.4 1 5.3 5 26.3
Oxytetracycline (30 lg) 19 100 0 0 0 0
Penicillin G (10 lg) 0 0 0 0 19 100
Streptomycin (10 lg) 8 42.1 2 10.5 9 47.3
Tetracycline (10 lg) 19 100 0 0 0 0
Tobramycin (10 lg) 17 89.5 0 0 2 10.5
Trimethoprim-sulfamethoxazole (25 lg) 10 52.6 2 10.5 7 36.8
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Figure 1 Bioﬁlm producing potential of Aeromonas isolates isolated from chicken feces.
484 I.H. Igbinosafeces. This suggests a potential group at risk for Aeromonas
gastroenteric diseases and the dissemination of Aeromonas to
other animals or humans with close contact and the wider
community. Periodical screening of poultry birds across differ-
ent geographical location is essential.
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